Cart 2

Drozitumab (Synonyms: USP MAB 003, MONOCLONAL IGG1 [USP-RS]; ANTI-DR5 RHUMAB-DR5)

Cat.#: 176820

Size:

Special Price 112.9 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Drozitumab (Synonyms: USP MAB 003, MONOCLONAL IGG1 [USP-RS]; ANTI-DR5 RHUMAB-DR5)
  • Documents
  • Description
    Anti-TNFRSF10B / TRAILR2 / CD262 Antibody (Drozitumab)
  • Tested applications
    ELISA
  • Species reactivity
    Human TNFRSF10B / TRAILR2 / CD262
  • Alternative names
    USP MAB 003, MONOCLONAL IGG1 [USP-RS] antibody; ANTI-DR5 RHUMAB-DR5 antibody
  • Isotype
    IgG1
  • Preparation
    Recombinant expression and purified from CHO cells.
  • Clonality
    Monoclonal
  • Formulation
    0.1 M Pro-Ac, 20 mM Arg, pH 5.0
  • Storage instructions
    -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
  • Validations

    SDS-PAGE

    SDS-PAGE

    Anti-TNFRSF10B / TRAILR2 / CD262 Antibody (drozitumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

    SEC-HPLC

    SEC-HPLC

    The purity of Anti-TNFRSF10B / TRAILR2 / CD262 Antibody (drozitumab) is 99.68%, determined by SEC-HPLC.

    Bioactivity: ELISA

    Bioactivity: ELISA

    Immobilized Cynomolgus TRAIL R2/DR5/ TNFRSF10B Protein, His Tag at 2 ug/mL can bind drozitumab, EC50=0.1257 ug/mL.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"